Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma

類似資料

• CEP72‐ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next‐generation sequencing
  著者:: Zhu, You‐cai, 等
  出版事項: (2018)
• Dual drive coexistence of EML4‐ALK and TPM3‐ROS1 fusion in advanced lung adenocarcinoma
  著者:: Zhu, You‐cai, 等
  出版事項: (2017)
• Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib
  著者:: Chen, Hua-fei, 等
  出版事項: (2018)
• ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib
  著者:: Xu, Shuguang, 等
  出版事項: (2019)
• Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
  著者:: Nakaoku, Takashi, 等
  出版事項: (2014)